Table of Contents Global NSCLS Drugs Market Research Report 2021, Forecast to 2026 1 Market Study Overview 1.1 Study Objectives 1.2 NSCLS Drugs Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 NSCLS Drugs Segment by Type 2.1.1 EGFR Targeting 2.1.2 ALK Targeting 2.1.3 PD-1/PD-L1 Targeting 2.1.4 Gemcitabine 2.1.5 Cisplatin/Carboplatin 2.1.6 Pemetrexed 2.1.7 Paclitaxel 2.1.8 Others 2.2 Market Analysis by Application 2.2.1 ≤ 30 Years Old 2.2.2 31 - 45 Years Old 2.2.3 46 - 60 Years Old 2.2.4 ＞ 60 Years Old 2.3 Global NSCLS Drugs Market Comparison by Regions (2016-2026) 2.3.1 Global NSCLS Drugs Market Size (2016-2026) 2.3.2 North America NSCLS Drugs Status and Prospect (2016-2026) 2.3.3 Europe NSCLS Drugs Status and Prospect (2016-2026) 2.3.4 China NSCLS Drugs Status and Prospect (2016-2026) 2.3.5 Japan NSCLS Drugs Status and Prospect (2016-2026) 2.3.6 Southeast Asia NSCLS Drugs Status and Prospect (2016-2026) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): NSCLS Drugs Industry Impact 2.5.1 NSCLS Drugs Business Impact Assessment - Covid-19 2.5.2 Market Trends and NSCLS Drugs Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global NSCLS Drugs Sales and Market Share by Manufacturer (2016-2021) 3.2 Global NSCLS Drugs Revenue and Market Share by Manufacturer (2016-2021) 3.3 Global NSCLS Drugs Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 NSCLS Drugs Manufacturer Market Share 3.5 Top 10 NSCLS Drugs Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into NSCLS Drugs Market 3.7 Key Manufacturers NSCLS Drugs Key Manufacturers 3.8 Mergers & Acquisitions Planning 4 Analysis of NSCLS Drugs Industry Key Manufacturers 4.1 Roche 4.1.1 Compan Detail 4.1.2 Roche NSCLS Drugs Product Introduction, Application and Specification 4.1.3 Roche 166 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.1.4 Main Business Overview 4.1.5 Roche News 4.2 Novartis 4.2.1 Compan Detail 4.2.2 Novartis NSCLS Drugs Product Introduction, Application and Specification 4.2.3 Novartis NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.2.4 Main Business Overview 4.2.5 Roche News 4.3 Pfizer 4.3.1 Compan Detail 4.3.2 Pfizer NSCLS Drugs Product Introduction, Application and Specification 4.3.3 Pfizer NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.3.4 Main Business Overview 4.3.5 Pfizer News 4.4 Merck 4.4.1 Compan Detail 4.4.2 Merck NSCLS Drugs Product Introduction, Application and Specification 4.4.3 Merck NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.4.4 Main Business Overview 4.4.5 Merck News 4.5 Bristol-Myers Squibb 4.5.1 Compan Detail 4.5.2 Merck NSCLS Drugs Product Introduction, Application and Specification 4.5.3 Bristol-Myers Squibb NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.5.4 Main Business Overview 4.5.5 Bristol-Myers Squibb News 4.6 Eli Lilly and Company 4.6.1 Compan Detail 4.6.2 Eli Lilly and Company NSCLS Drugs Product Introduction, Application and Specification 4.6.3 Eli Lilly and Company NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.6.4 Main Business Overview 4.6.5 Eli Lilly and Company News 4.7 Takeda Pharmaceutical 4.7.1 Compan Detail 4.7.2 Takeda Pharmaceutical NSCLS Drugs Product Introduction, Application and Specification 4.7.3 Takeda Pharmaceutical NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.7.4 Main Business Overview 4.7.4 Main Business Overview 4.8 Boehringer-Ingelheim 4.8.1 Compan Detail 4.8.2 Boehringer-Ingelheim NSCLS Drugs Product Introduction, Application and Specification 4.8.3 Boehringer-Ingelheim NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.8.4 Main Business Overview 4.8.5 Boehringer-Ingelheim News 4.9 AstraZeneca 4.9.1 Compan Detail 4.9.2 AstraZeneca NSCLS Drugs Product Introduction, Application and Specification 4.9.3 AstraZeneca NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.9.4 Main Business Overview 4.9.5 AstraZeneca News 4.10 Betta Pharmaceuticals 4.10.1 Compan Detail 4.10.2 Betta Pharmaceuticals NSCLS Drugs Product Introduction, Application and Specification 4.10.3 Betta Pharmaceuticals NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.10.4 Main Business Overview 4.10.5 Betta Pharmaceuticals News 4.11 Qilu Oharmaceutical 4.11.1 Compan Detail 4.11.2 Qilu Oharmaceutical NSCLS Drugs Product Introduction, Application and Specification 4.11.3 Qilu Oharmaceutical NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.11.4 Main Business Overview 4.11.5 Qilu Oharmaceutical News 4.12 Pierre Fabre Medicament 4.12.1 Compan Detail 4.12.2 Pierre Fabre Medicament NSCLS Drugs Product Introduction, Application and Specification 4.12.3 Pierre Fabre Medicament NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.12.4 Main Business Overview 4.12.5 Pierre Fabre Medicament News 4.13 Chemo Wanbang Biopharma 4.13.1 Company Details 4.13.2 Chemo Wanbang Biopharma NSCLS Drugs Product Introduction, Application and Specification 4.13.3 Chemo Wanbang Biopharma NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.13.4 Main Business Overview 4.13.5 Chemo Wanbang Biopharma News 4.14 Hetero Drugs 4.14.1 Compan Detail 4.14.2 Hetero Drugs NSCLS Drugs Product Introduction, Application and Specification 4.14.3 Hetero Drugs NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.14.4 Main Business Overview 4.14.5 Hetero Drugs News 4.15 Harbin Gloria Pharmaceuticals 4.15.1 Compan Detail 4.15.2 Harbin Gloria Pharmaceuticals NSCLS Drugs Product Introduction, Application and Specification 4.15.3 Harbin Gloria Pharmaceuticals NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.15.4 Main Business Overview 4.15.5 Harbin Gloria Pharmaceuticals News 4.16 Luoxin Pharmaceutical 4.16.1 Compan Detail 4.16.2 Luoxin Pharmaceutical NSCLS Drugs Product Introduction, Application and Specification 4.16.3 Luoxin Pharmaceutical NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.16.4 Main Business Overview 4.16.5 Luoxin Pharmaceutical News 4.17 Teva Pharmaceutical 4.17.1 Compan Detail 4.17.2 Teva Pharmaceutical NSCLS Drugs Product Introduction, Application and Specification 4.17.3 Teva Pharmaceutical NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.17.4 Main Business Overview 4.17.5 Teva Pharmaceutical News 4.18 Mylan 4.18.1 Compan Detail 4.18.2 Mylan NSCLS Drugs Product Introduction, Application and Specification 4.18.3 Mylan NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.18.4 Main Business Overview 4.18.5 Mylan News 4.19 Sun Pharmaceutical 4.19.1 Compan Detail 4.19.2 Sun Pharmaceutical NSCLS Drugs Product Introduction, Application and Specification 4.19.3 Sun Pharmaceutical NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.19.4 Main Business Overview 4.19.5 Sun Pharmaceutical News 4.20 Fosun Pharma 4.20.1 Compan Detail 4.20.2 Fosun Pharma NSCLS Drugs Product Introduction, Application and Specification 4.20.3 Fosun Pharma NSCLS Drugs Sales, Price, Cost, Gross Margin, and Revenue (2016-2021) 4.20.4 Main Business Overview 4.20.5 Fosun Pharma News 5 Global NSCLS Drugs Market Segment by Big Type 5.1 Global NSCLS Drugs Revenue, Sales and Market Share by Big Type (2016-2021) 5.1.1 Global NSCLS Drugs Sales and Market Share by Big Type (2016-2021) 5.1.2 Global NSCLS Drugs Revenue and Market Share by Big Type (2016-2021) 5.2 EGFR Targeting Sales Growth Rate and Price 5.2.1 Global EGFR Targeting Sales Growth Rate (2016-2021) 5.2.2 Global EGFR Targeting Price (2016-2021) 5.3 ALK Targeting Sales Growth Rate and Price 5.3.1 Global ALK Targeting Sales Growth Rate (2016-2021) 5.3.2 Global ALK Targeting Price (2016-2021) 5.4 PD-1/PD-L1 Targeting Sales Growth Rate and Price 5.4.1 Global PD-1/PD-L1 Targeting Sales Growth Rate (2016-2021) 5.4.2 Global PD-1/PD-L1 Targeting Price (2016-2021) 5.5 Gemcitabine Sales Growth Rate and Price 5.5.1 Global Gemcitabine Sales Growth Rate (2016-2021) 5.5.2 Global Gemcitabine Price (2016-2021) 5.6 Cisplatin/Carboplatin Sales Growth Rate and Price 5.6.1 Global Cisplatin/Carboplatin Sales Growth Rate (2016-2021) 5.6.2 Global Cisplatin/Carboplatin Price (2016-2021) 5.7 Pemetrexed Sales Growth Rate and Price 5.7.1 Global Pemetrexed Sales Growth Rate (2016-2021) 5.7.2 Global Pemetrexed Price (2016-2021) 5.8 Paclitaxel Sales Growth Rate and Price 5.8.1 Global Paclitaxel Sales Growth Rate (2016-2021) 5.8.2 Global Paclitaxel Price (2016-2021) 5.9 Others Sales Growth Rate and Price 5.9.1 Global Others Sales Growth Rate (2016-2021) 5.9.2 Global Others Price (2016-2021) 6 Global NSCLS Drugs Market Segment by Big Application 6.1 Global NSCLS Drugs Sales Market Share by Big Application (2016-2021) 6.2 ≤ 30 Years Old Sales Growth Rate (2016-2021) 6.3 31 - 45 Years Old Sales Growth Rate (2016-2021) 6.4 46 - 60 Years Old Sales Growth Rate (2016-2021) 6.5 ＞ 60 Years Old Sales Growth Rate (2016-2021) 7 Global NSCLS Drugs Forecast 7.1 Global NSCLS Drugs Revenue, Sales and Growth Rate (2021-2026) 7.2 NSCLS Drugs Market Forecast by Regions (2021-2026) 7.2.1 North America NSCLS Drugs Market Forecast (2021-2026) 7.2.2 Europe NSCLS Drugs Market Forecast (2021-2026) 7.2.3 China NSCLS Drugs Market Forecast (2021-2026) 7.2.4 Japan NSCLS Drugs Market Forecast (2021-2026) 7.2.5 Southeast Asia NSCLS Drugs Market Forecast (2021-2026) 7.2.6 Other Regions NSCLS Drugs Market Forecast (2021-2026) 7.3 NSCLS Drugs Market Forecast by Type (2021-2026) 7.3.1 Global NSCLS Drugs Sales Forecast by Type (2021-2026) 7.3.2 Global NSCLS Drugs Market Share Forecast by Type (2021-2026) 7.4 NSCLS Drugs Market Forecast by Application (2021-2026) 7.4.1 Global NSCLS Drugs Sales Forecast by Application (2021-2026) 7.4.2 Global NSCLS Drugs Market Share Forecast by Application (2021-2026) 8 Market Analysis 8.1.1 Market Overview 8.1.2 Market Opportunities 8.1.3 Market Risk 8.1.4 Market Driving Force 8.1.5 Porter's Five Forces Analysis 8.1.6 SWOT Analysis 9 NSCLS Drugs Related Market Analysis 9.1 Upstream Analysis 9.1.1 Macro Analysis of Upstream Markets 9.1.2 Key Players in Upstream Markets 9.1.3 Upstream Market Trend Analysis 9.1.4 NSCLS Drugs Manufacturing Cost Analysis 9.2 Downstream Market Analysis 9.2.1 Macro Analysis of Down Markets 9.2.2 Key Players in Down Markets 9.2.3 Downstream Market Trend Analysis 9.2.4 Sales Channel, Distributors, Traders and Dealers 10 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture NSCLS Drugs Figure Market Concentration Ratio and Market Maturity Analysis of NSCLS Drugs Figure Bottom-up and Top-down Approaches for This Report Figure Part of Our External Database Figure Part of Our External Database Figure Key Executives Interviewed Table Global NSCLS Drugs Market Size by Big Type Figure Global Market Share of NSCLS Drugs by Big Type in 2020 Figure EGFR Targeting Picture (2016-2021) Figure ALK Targeting Picture (2016-2021) Figure PD-1/PD-L1 Targeting Picture (2016-2021) Figure Gemcitabine Picture (2016-2021) Figure Cisplatin/Carboplatin Picture (2016-2021) Figure Pemetrexed Picture (2016-2021) Figure Paclitaxel Picture (2016-2021) Global NSCLS Drugs Market Size by Big Application Table Global NSCLS Drugs Market Size by Application Figure Global NSCLS Drugs Market Share by Big Application in 2020 Figure ≤ 30 Years Old Picture Figure 31 - 45 Years Old Picture Figure 46 - 60 Years Old Picture Figure ＞ 60 Years Old Picture Table Global NSCLS Drugs Comparison by Regions (M USD) （2016-2026） Figure Global NSCLS Drugs Market Size (Million US$) (2016-2026) Figure North America NSCLS Drugs Revenue (Million US$) Growth Rate (2016-2026) Figure Europe NSCLS Drugs Revenue (Million US$) Growth Rate (2016-2026) Figure China NSCLS Drugs Revenue (Million US$) Growth Rate (2016-2026) Figure Japan NSCLS Drugs Revenue (Million US$) Growth Rate (2016-2026) Figure Southeast Asia NSCLS Drugs Revenue (Million US$) Growth Rate (2016-2026) Table Business Impact Assessment - Covid-19 Table Market Trends and NSCLS Drugs Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global NSCLS Drugs Sales by Manufacturer (2016-2021) Figure Global NSCLS Drugs Sales Market Share by Manufacturer in 2020 Table Global NSCLS Drugs Revenue by Manufacturer (2016-2021) Figure Global NSCLS Drugs Revenue Market Share by Manufacturer in 2020 Table Global NSCLS Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 NSCLS Drugs Manufacturer (Revenue) Market Share in 2020 Figure Top 10 NSCLS Drugs Manufacturer (Revenue) Market Share in 2020 Table Date of Key Manufacturers Enter into NSCLS Drugs Market Table Key Manufacturers NSCLS Drugs Product Type Table Mergers & Acquisitions Planning Table Roche Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Roche Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021 Table Company One Main Business Table Company One Recent Development Table Novartis Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Novartis Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Novartis Recent Development Table Pfizer Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Pfizer Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Pfizer Main Business Table Pfizer Recent Development Table Merck Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Merck Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Merck Main Business Table Merck Recent Development Table Merck Main Business Table Merck Recent Development Table Bristol-Myers Squibb Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Bristol-Myers Squibb Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Bristol-Myers Squibb Main Business Table Bristol-Myers Squibb Recent Development Table Eli Lilly and Company Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Eli Lilly and Company Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Eli Lilly and Company Main Business Table Eli Lilly and Company Recent Development Table Takeda Pharmaceutical Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Takeda Pharmaceutical Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Takeda Pharmaceutical Main Business Table Takeda Pharmaceutical Recent Development Table Boehringer-Ingelheim Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Boehringer-Ingelheim Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Boehringer-Ingelheim Main Business Table Boehringer-Ingelheim Recent Development Table AstraZeneca Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of AstraZeneca Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table AstraZeneca Main Business Table AstraZeneca Recent Development Table Betta Pharmaceuticals Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Betta Pharmaceuticals Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Betta Pharmaceuticals Main Business Table Betta Pharmaceuticals Recent Development Table Qilu Oharmaceutical Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Qilu Oharmaceutical Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Qilu Oharmaceutical Main Business Table Qilu Oharmaceutical Recent Development Table Pierre Fabre Medicament Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Pierre Fabre Medicament Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Pierre Fabre Medicament Main Business Table Pierre Fabre Medicament Recent Development Table Chemo Wanbang Biopharma Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Chemo Wanbang Biopharma Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Chemo Wanbang Biopharma Main Business Table Chemo Wanbang Biopharma Recent Development Table Hetero Drugs Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Hetero Drugs Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Hetero Drugs Main Business Table Hetero Drugs Recent Development Table Luoxin Pharmaceutical Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Luoxin Pharmaceutical Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Luoxin Pharmaceutical Main Business Table Luoxin Pharmaceutical Recent Development Table Teva Pharmaceutical Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Teva Pharmaceutical Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Teva Pharmaceutical Main Business Table Teva Pharmaceutical Recent Development Table Mylan Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Mylan Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Mylan Main Business Table Mylan Recent Development Table Sun Pharmaceutical Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Sun Pharmaceutical Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Sun Pharmaceutical Main Business Table Sun Pharmaceutical Recent Development Table Fosun Pharma Company Profile Table NSCLS Drugs Product Introduction, Application and Specification of Fosun Pharma Table NSCLS Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021 Table Fosun Pharma Main Business Table Fosun Pharma Recent Development Figure Global NSCLS Drugs Sales and Growth Rate (2016-2021) Figure Global NSCLS Drugs Revenue and Growth Rate (2016-2021) Table Global NSCLS Drugs Sales by Regions (2016-2021) Figure Global NSCLS Drugs Sales Market Share by Regions in 2020 Table Global NSCLS Drugs Revenue by Regions (2016-2021) Figure Global NSCLS Drugs Revenue Market Share by Regions in 2020 Figure North America NSCLS Drugs Sales and Growth Rate (2016-2021) Figure Europe NSCLS Drugs Sales and Growth Rate (2016-2021) Figure China NSCLS Drugs Sales and Growth Rate (2016-2021) Figure Japan NSCLS Drugs Sales and Growth Rate (2016-2021) Figure Southeast Asia NSCLS Drugs Sales and Growth Rate (2016-2021) Figure Other Regions NSCLS Drugs Sales and Growth Rate (2016-2021) Table Global NSCLS Drugs Sales by Big Type (2016-2021) Table Global NSCLS Drugs Sales Market Share by Big Type (2016-2021) Figure Global NSCLS Drugs Sales Market Share by Big Type in 2019 Table Global NSCLS Drugs Revenue by Big Type (2016-2021) Table Global NSCLS Drugs Revenue Market Share by Big Type (2016-2021) Table Global NSCLS Drugs Revenue Market Share by Big Type in 2019 Figure Global EGFR Targeting Sales Growth Rate (2016-2021) Figure Global EGFR Targeting Price (2016-2021) Figure Global ALK Targeting Sales Growth Rate (2016-2021) Figure Global ALK Targeting Price (2016-2021) Figure Global PD-1/PD-L1 Targeting Sales Growth Rate (2016-2021) Figure Global PD-1/PD-L1 Targeting Price (2016-2021) Figure Global Gemcitabine Sales Growth Rate (2016-2021) Figure Global Gemcitabine Price (2016-2021) Figure Global Pemetrexed Sales Growth Rate (2016-2021) Figure Global Pemetrexed Price (2016-2021) Figure Global Paclitaxel Sales Growth Rate (2016-2021) Figure Global Paclitaxel Price (2016-2021) Figure Global Others Sales Growth Rate (2016-2021) Table Global NSCLS Drugs Sales by Big Application (2016-2021) Table Global NSCLS Drugs Sales Market Share by Big Application (2016-2021) Figure Global NSCLS Drugs Sales Market Share by Big Application in 2019 Figure Global ≤ 30 Years Old Sales Growth Rate (2016-2021) Figure Global 31 - 45 Years Old Sales Growth Rate (2016-2021) Figure Global 46 - 60 Years Old Sales Growth Rate (2016-2021) Figure Global ＞ 60 Years Old Sales Growth Rate (2016-2021) Figure Global NSCLS Drugs Sales and Growth Rate (2021-2026) Figure Global NSCLS Drugs Revenue and Growth Rate (2021-2026) Table Global NSCLS Drugs Sales Forecast by Regions (2021-2026) Table Global NSCLS Drugs Market Share Forecast by Regions (2021-2026) Figure North America Sales NSCLS Drugs Market Forecast (2021-2026) Figure Europe Sales NSCLS Drugs Market Forecast (2021-2026) Figure China Sales NSCLS Drugs Market Forecast (2021-2026) Figure Japan Sales NSCLS Drugs Market Forecast (2021-2026) Figure Southeast Asia Sales NSCLS Drugs Market Forecast (2021-2026) Figure Other Regions Sales NSCLS Drugs Market Forecast (2021-2026) Table Global NSCLS Drugs Sales Forecast by Type (2021-2026) Table Global NSCLS Drugs Market Share Forecast by Type (2021-2026) Table Global NSCLS Drugs Sales Forecast by Application (2021-2026) Table Global NSCLS Drugs Market Share Forecast by Application (2021-2026) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of NSCLS Drugs Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure North America NSCLS Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America NSCLS Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe NSCLS Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe NSCLS Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan NSCLS Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan NSCLS Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China NSCLS Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure China NSCLS Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Roche Novartis Pfizer Merck Bristol-Myers Squibb Eli Lilly and Company Takeda Pharmaceutical Boehringer-Ingelheim AstraZeneca Betta Pharmaceuticals Qilu Oharmaceutical Pierre Fabre Medicament Chemo Wanbang Biopharma Hetero Drugs Harbin Gloria Pharmaceuticals Luoxin Pharmaceutical Teva Pharmaceutical Mylan